Dr Nkiruka, Ezenwajiaku, completed her residency in Internal Medicine at Massachusetts General Hospital in Boston and her fellowship training in Hematology/Oncology at Washington University School of Medicine in St. Louis, Missouri and earned her medical degree from Case Western Reserve University School of Medicine, in Cleavland, Ohio. Dr Nk, is Board Certified in Internal medicine and Board Eligible in Hematology & Oncology and is an avid participant in clinical trials.

Dr Pereira is an Associate Professor of Medicine who joined the University of Miami in 2003 and became the Director for Clinical Operations for the Adult Stem Cell Transplant Program in 2016. She is the immediate past president of the University of Miami Hospital and Clinics Medical Staff and her clinical and research interest are centered on stem cell transplant and cellular therapy for Plasma Cell Disorders, Germ Cell Tumors and benign diseases.

Dr Jimenez Jimenez, who joined the Division of Transplantation and Cell Therapy in 2016, leads Sylvester's Mismatched Allogeneic Transplant Program. His clinical and research work is dedicated to improving access to Hematopoietic Cell Transplantation (HCT) for ethnically diverse patients who lack suitable donors. A national leader in mismatched HCT, Dr Jimenez chairs multiple trials and played a key role in establishing Sylvester's program. He also focuses on strategies to reduce relapse risk in patients with acute leukemias and myeloid neoplasms post-transplant.

Dr Lekakis is a Professor of Medicine who joined the University of Miami in 2010 and became an attending physician for Hemotology/Oncology and Blood and Marrow Transplantation in 2012. He has since started the CAR-T trials, performed the first CAR-T for solid tumors, and transplanted adult sickle cell disease patients. Dr Lekakis is a member of the USA CAR-T Consortium and several CIBMTR committees including CAR-T, Lymphoma, Leukemia, and GVHD. His main interests are CAR-T and GVHD.

Dr Trent Wang is an Associate Professor of Clinical Medicine within the Division of Transplantation and Cellular Therapy. Since joining Sylvester Comprehensive Cancer Center, his clinical focus has been treating patients with hematologic cancers who require allogeneic hematopoietic stem cell transplantation and other cellular therapies. Dr Wang's research focuses on complications of allogeneic hematopoietic stem cell transplantation, including conducting interventional, behavioral and retrospective studies of graft-versus-host disease, infectious transplant complications, and transplant survivorship. Dr Wang also studies the outcomes of immune effector cell therapies such as CAR-T cells for various oncologic indications.

Dr Calfa is an Associate Professor of Clinical Medicine at the University of Miami Miller School of Medicine, Associate Director of Community Outreach and Medical Co-Director of the Survivorship Cancer Program at Sylvester Comprehensive Cancer Center. She also serves as the Clinical Research Lead for the Breast Site Disease Group and Physician Leader of the Genetic Predisposition Syndrome Initiative at Sylvester Comprehensive Cancer Center. Furthermore, she leads Sylvester's Multidisciplinary Survivorship Clinic Program and plays a key role in the Adolescent and Young Adult Steering Committee.